122 related articles for article (PubMed ID: 16625655)
1. Solid state interactions between the proton pump inhibitor omeprazole and various enteric coating polymers.
Stroyer A; McGinity JW; Leopold CS
J Pharm Sci; 2006 Jun; 95(6):1342-53. PubMed ID: 16625655
[TBL] [Abstract][Full Text] [Related]
2. Degradation of omeprazole induced by enteric polymer solutions and aqueous dispersions: HPLC investigations.
Riedel A; Leopold CS
Drug Dev Ind Pharm; 2005 Jan; 31(2):151-60. PubMed ID: 15773282
[TBL] [Abstract][Full Text] [Related]
3. Quantification of omeprazole degradation by enteric coating polymers: an UV-VIS spectroscopy study.
Riedel A; Leopold CS
Pharmazie; 2005 Feb; 60(2):126-30. PubMed ID: 15739901
[TBL] [Abstract][Full Text] [Related]
4. Solid-state interactions at the core-coat interface: physicochemical characterization of enteric-coated omeprazole pellets without a protective sub-coat.
Sharma VD; Akocak S; Ilies MA; Fassihi R
AAPS PharmSciTech; 2015 Aug; 16(4):934-43. PubMed ID: 25595125
[TBL] [Abstract][Full Text] [Related]
5. Blends of reverse enteric polymer with Enteric and pH-independent polymers: mechanistic investigations for tailoring drug release.
Menjoge AR; Kulkarni MG
Biomacromolecules; 2007 Jan; 8(1):240-51. PubMed ID: 17206813
[TBL] [Abstract][Full Text] [Related]
6. Investigations on the thermal behavior of omeprazole and other sulfoxides.
Rosenblatt KM; Bunjes H; Seeling A; Oelschläger H
Pharmazie; 2005 Jul; 60(7):503-7. PubMed ID: 16076075
[TBL] [Abstract][Full Text] [Related]
7. Dissolution test for liquid formulations of omeprazole enteric-coated products.
Jang HJ; Kang BC; Shin WG; Lee S
Ann Pharmacother; 2003 Jan; 37(1):150-1. PubMed ID: 12503954
[No Abstract] [Full Text] [Related]
8. Effect of Elevated pH on the Commercial Enteric-Coated Omeprazole Pellets Resistance: Patent Review and Multisource Generics Comparison.
Mohylyuk V; Yerkhova A; Katynska M; Sirko V; Patel K
AAPS PharmSciTech; 2021 Jun; 22(5):188. PubMed ID: 34159427
[TBL] [Abstract][Full Text] [Related]
9. Instantaneous enteric nano-encapsulation of omeprazole: pharmaceutical and pharmacological evaluation.
Bendas ER; Abdelbary AA
Int J Pharm; 2014 Jul; 468(1-2):97-104. PubMed ID: 24746414
[TBL] [Abstract][Full Text] [Related]
10. The manufacture and characterisation of hot-melt extruded enteric tablets.
Andrews GP; Jones DS; Diak OA; McCoy CP; Watts AB; McGinity JW
Eur J Pharm Biopharm; 2008 May; 69(1):264-73. PubMed ID: 18164604
[TBL] [Abstract][Full Text] [Related]
11. Enhanced enteric properties and stability of shellac films through composite salts formation.
Limmatvapirat S; Limmatvapirat C; Puttipipatkhachorn S; Nuntanid J; Luangtana-Anan M
Eur J Pharm Biopharm; 2007 Nov; 67(3):690-8. PubMed ID: 17576057
[TBL] [Abstract][Full Text] [Related]
12. Nefopam hydrochloride compatibility and stability with selected proton pump inhibitors in bionolyte G5 injection for intravenous infusion.
Kambia NK; Luyckx M; Dine T; Dupin-Spriet T; Gressier B; Brunet C
J Clin Pharm Ther; 2009 Feb; 34(1):25-31. PubMed ID: 19125900
[TBL] [Abstract][Full Text] [Related]
13. In vitro dissolution of proton-pump inhibitor products intended for paediatric and geriatric use in physiological bicarbonate buffer.
Liu F; Shokrollahi H
Int J Pharm; 2015 May; 485(1-2):152-9. PubMed ID: 25746736
[TBL] [Abstract][Full Text] [Related]
14. Stability of omeprazole in an extemporaneously prepared oral liquid.
Quercia RA; Fan C; Liu X; Chow MS
Am J Health Syst Pharm; 1997 Aug; 54(16):1833-6. PubMed ID: 9269520
[TBL] [Abstract][Full Text] [Related]
15. Kinetics of omeprazole degradation in solid state.
Popielarz-Brzezińska M
Acta Pol Pharm; 2011; 68(5):753-7. PubMed ID: 21928721
[TBL] [Abstract][Full Text] [Related]
16. Effects of Kollicoat IR and hydroxypropyl-beta-cyclodextrin on the dissolution rate of omeprazole from its microparticles and enteric-coated capsules.
El-Badry M; Alanazi FK; Mahrous GM; Alsarra IA
Pharm Dev Technol; 2010; 15(5):500-10. PubMed ID: 19814584
[TBL] [Abstract][Full Text] [Related]
17. Photocatalytic and photoelectrocatalytic degradation of the drug omeprazole on nanocrystalline titania films in alkaline media: Effect of applied electrical bias on degradation and transformation products.
Tantis I; Bousiakou L; Frontistis Z; Mantzavinos D; Konstantinou I; Antonopoulou M; Karikas GA; Lianos P
J Hazard Mater; 2015 Aug; 294():57-63. PubMed ID: 25855613
[TBL] [Abstract][Full Text] [Related]
18. Use of bicarbonate buffer systems for dissolution characterization of enteric-coated proton pump inhibitor tablets.
Shibata H; Yoshida H; Izutsu K; Goda Y
J Pharm Pharmacol; 2016 Apr; 68(4):467-74. PubMed ID: 27019275
[TBL] [Abstract][Full Text] [Related]
19. Stability-enhanced hot-melt extruded amorphous solid dispersions via combinations of Soluplus® and HPMCAS-HF.
Alshahrani SM; Lu W; Park JB; Morott JT; Alsulays BB; Majumdar S; Langley N; Kolter K; Gryczke A; Repka MA
AAPS PharmSciTech; 2015 Aug; 16(4):824-34. PubMed ID: 25567525
[TBL] [Abstract][Full Text] [Related]
20. Development and evaluation of an omeprazole-based delayed-release liquid oral dosage form.
Ronchi F; Sereno A; Paide M; Sacré P; Guillaume G; Stéphenne V; Goole J; Amighi K
Int J Pharm; 2019 Aug; 567():118416. PubMed ID: 31175991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
